![]() |
|
|
Vol. 302, Issue 2, 774-780, August 2002
Institute of Biochemistry, Biological Research Center, Hungarian
Academy of Sciences, Szeged, Hungary (G.F., B.B., M. Szú.);
Department of Physiology, Albert Szent-Györgyi Medical Center,
Szeged University, Szeged, Hungary (M. Szi., G.H.); and Department of
Biochemistry and Molecular Biology, St. Louis University School of
Medicine, St. Louis, Missouri (C.J.C.)
Prolonged exposure to opioid agonists can induce adaptive changes
resulting in tolerance and dependence. Here, rats were rendered tolerant by subcutaneous injections of increasing doses of morphine from 10 to 60 mg/kg for 3, 5, or 10 consecutive days. Binding parameters of the µ-opioid receptor in subcellular fractions were measured with [3H]DAMGO
([D-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin).
Although the density of surface µ-sites did not change after the
5-day morphine treatment, up-regulation of synaptic plasma membrane
binding was detected after the 10-day drug administration. In contrast,
the number of µ-binding sites in a light vesicle or microsomal
fraction (MI) was elevated by 68 and 30% after 5 and 10 days of
morphine exposure, respectively. The up-regulated MI µ-sites
displayed enhanced coupling to G proteins compared with those detected
in saline-treated controls. Pertussis toxin catalyzed ADP ribosylation,
and Western blotting with specific antisera was used to quantitate
chronic morphine-induced changes in levels of various G protein
-subunits. Morphine treatment of 5 days and longer induced
significant increases in levels of G
o,
G
i1, and G
i2 in MI fractions that are
part of an adaptation process. Up-regulation of intracellular µ-sites
may be the result of post-translational changes and in part de novo
synthesis. The results provide the first evidence that distinct
regulation of intracellular µ-opioid receptor G protein coupling and
G protein levels may accompany the development of morphine tolerance.
This article has been cited by other articles:
![]() |
V. Fernandez-Duenas, O. Pol, P. Garcia-Nogales, L. Hernandez, E. Planas, and M. M. Puig Tolerance to the Antinociceptive and Antiexudative Effects of Morphine in a Murine Model of Peripheral Inflammation J. Pharmacol. Exp. Ther., July 1, 2007; 322(1): 360 - 368. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Xu, X. Wang, D. Zimmerman, E. S. Boja, J. Wang, E. J. Bilsky, and R. B. Rothman Chronic Morphine Up-Regulates G{alpha}12 and Cytoskeletal Proteins in Chinese Hamster Ovary Cells Expressing the Cloned {micro} Opioid Receptor J. Pharmacol. Exp. Ther., October 1, 2005; 315(1): 248 - 255. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Szucs, K. Boda, and A. R. Gintzler Dual Effects of DAMGO [D-Ala2,N-Me-Phe4,Gly5-ol]-Enkephalin and CTAP (D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2) on Adenylyl Cyclase Activity: Implications for {micro}-Opioid Receptor Gs Coupling J. Pharmacol. Exp. Ther., July 1, 2004; 310(1): 256 - 262. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. H. Ko, H. Lee, C. Harrison, M. J. Clark, H. F. Song, N. N. Naughton, J. H. Woods, and J. R. Traynor Studies of {micro}-, {kappa}-, and {delta}-Opioid Receptor Density and G Protein Activation in the Cortex and Thalamus of Monkeys J. Pharmacol. Exp. Ther., July 1, 2003; 306(1): 179 - 186. [Abstract] [Full Text] [PDF] |
||||